Table of Contents
PRINCETON, N.J. — Marc Kikuchi has been named chief executive officer of North American generics at Dr. Reddy’s Laboratories Ltd.
“Dr. Reddy’s is a great company with a wide portfolio and remarkable heritage,” says Kikuchi. “I am excited to join Dr. Reddy’s and look forward to leveraging my past experiences to steer the company’s new growth areas.”
Kikuchi has more than 20 years of experience in the pharmaceutical industry, with extensive knowledge and understanding of generics. He joins Dr. Reddy’s from Zydus Pharmaceuticals Inc. where he had served as CEO of the Americas since 2016. Prior to joining Zydus, he held professional leadership roles of increasing responsibility with AmerisourceBergen Corp., Medrad Inc., PRTM, Johnson & Johnson and Incyte Pharmaceuticals. He holds a bachelor’s degree in molecular and cell biology with a biochemistry emphasis from the University of California at Berkeley, and a Master of Business Administration from Carnegie Mellon University in strategy, marketing, and operations management.
